Delirium and Benzodiazepines Associated With Prolonged ICU Stay in Critically Ill Infants and Young Children

Heidi A B Smith1, Maalobeeka Gangopadhyay, Christina M Goben

  • 11Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN. 2Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN. 3Department of Psychiatry, New York-Presbyterian Morgan Stanley Children's Hospital, New York, NY. 4Department of Pediatrics, University of South Carolina School of Medicine Greenville, Greenville, SC. 5Department of Psychiatry, Children's Hospital of Philadelphia, Philadelphia, PA. 6Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN. 7Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN. 8Department of Internal Medicine, Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN. 9Tennessee Valley Veterans Administration (VA) Geriatric Research Education Clinical Center (GRECC), Nashville, TN. 10Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN.

Insights

Pediatric delirium in the ICU is linked to poorer discharge outcomes. Reducing benzodiazepine exposure may decrease delirium duration and improve patient recovery.

Area of Science:

  • Pediatric Critical Care Medicine
  • Neuroscience
  • Pharmacology

Background:

  • Delirium is common in critically ill children but its outcomes and risk factors are not fully understood.
  • Identifying modifiable risk factors is crucial for improving care in pediatric intensive care units (PICUs).

Purpose of the Study:

  • To investigate the association between pediatric delirium and modifiable risk factors, specifically benzodiazepine exposure.
  • To determine the impact of delirium on short-term outcomes in critically ill children.

Main Methods:

  • Secondary analysis of data from a prospective validation study of the Preschool Confusion Assessment Method for the ICU.
  • Included critically ill patients aged 6 months to 5 years in a tertiary-level PICU.
  • Used Cox regression, negative binomial regression, and multinomial logistic regression to analyze risk factors and outcomes.

Main Results:

  • Delirium was diagnosed in 44% of the 300-patient cohort, with a median duration of 1-2 days.
  • Delirium significantly decreased the likelihood of ICU discharge in preschool-aged children.
  • Increased benzodiazepine exposure correlated with lower ICU discharge likelihood, longer delirium duration, and increased daily delirium risk.

Conclusions:

  • Pediatric delirium is associated with reduced likelihood of ICU discharge.
  • Benzodiazepine exposure is a significant risk factor for delirium development, duration, and poorer outcomes.
  • Reducing benzodiazepine exposure is a potential strategy to mitigate harm in critically ill pediatric patients.
Abstract

Related Concept Videos

CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.5K
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.1K
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
434
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.2K
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
820